The Statistics and Data Management Core, as a centralized resource of the UCSD SPOTRIAS Center, provides expertise in study design and data management, quality control, and analysis for the entire Center's translational acute stroke research. The biostatistical responsibilities of the Core include collaborating on the experimental design of every clinical trial protocol and research project;developing and generating the randomization sequence for each study;performing interim, preliminary, and final statistical analyses on study data;and assisting with the preparation of reports and publications. All UCSD SPOTRIAS Center study data are managed through Core A. Every aspect of the data capture process, including design of case report forms, maintenance of centralized patient data files, and production of special purpose and routine statistical reports on accumulating data, is coordinated through the data management operations of the Core. The Core's computing environment consists of approximately 9 workstations connected in a client-server architecture, using TCP/IP local area network (LAN) with three servers (web, data, and archive). The network is secured behind a firewall. Data management is conducted through the PostgreSQL and Mysql relational database management systems. The quality assurance (QA) program of the Statistics and Data Management Core is extensive and comprehensive. While computerized, real-time monitoring of all study data is primary and fundamental, QA coverage extends to study initiation, project investigator and support staff training in data entry, and document development and production (e.g., training manuals, manuals of procedures, newsletters). Data entry is distributed with edit checking conducted both at the time of entry and longitudinally.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS044148-10
Application #
8377345
Study Section
Special Emphasis Panel (ZNS1-SRB-G)
Project Start
Project End
2014-04-30
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
10
Fiscal Year
2012
Total Cost
$471,932
Indirect Cost
$87,116
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Chen, P M; Nguyen, D T; Ho, J P et al. (2018) Factors Influencing Acute Stroke Thrombolytic Treatments in Hispanics In the San Diego Region. Austin J Cerebrovasc Dis Stroke 5:
Lyden, Patrick; Hemmen, Thomas; Grotta, James et al. (2016) Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2). Stroke 47:2888-2895
Guluma, Kama Z; Liebeskind, David S; Raman, Rema et al. (2015) Feasibility and Safety of Using External Counterpulsation to Augment Cerebral Blood Flow in Acute Ischemic Stroke-The Counterpulsation to Upgrade Forward Flow in Stroke (CUFFS) Trial. J Stroke Cerebrovasc Dis 24:2596-604
Neil, William P; Raman, Rema; Hemmen, Thomas M et al. (2015) Association of Hispanic ethnicity with acute ischemic stroke care processes and outcomes. Ethn Dis 25:19-23
Schlick, Konrad H; Hemmen, Thomas M; Lyden, Patrick D (2015) Seizures and Meperidine: Overstated and Underutilized. Ther Hypothermia Temp Manag 5:223-7
Spokoyny, Ilana; Raman, Rema; Ernstrom, Karin et al. (2015) Defining mild stroke: outcomes analysis of treated and untreated mild stroke patients. J Stroke Cerebrovasc Dis 24:1276-81
Spokoyny, Ilana; Raman, Rema; Ernstrom, Karin et al. (2015) Accuracy of First Recorded ""Last Known Normal"" Times of Stroke Code Patients. J Stroke Cerebrovasc Dis 24:2467-73
Coffman, Clarity R; Raman, Rema; Ernstrom, Karin et al. (2015) The ""DeyeCOM Sign"": Predictive Value in Acute Stroke Code Evaluations. J Stroke Cerebrovasc Dis 24:1299-304
Lyden, Patrick D; Hemmen, Thomas M; Grotta, James et al. (2014) Endovascular therapeutic hypothermia for acute ischemic stroke: ICTuS 2/3 protocol. Int J Stroke 9:117-25
Spokoyny, Ilana; Raman, Rema; Ernstrom, Karin et al. (2014) Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients. J Stroke Cerebrovasc Dis 23:1046-50

Showing the most recent 10 out of 53 publications